Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update.

Amstutz, Ursula

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update. [electronic resource] - Clinical pharmacology and therapeutics 02 2018 - 210-216 p. digital

Publication Type: Journal Article; Practice Guideline; Systematic Review

1532-6535

10.1002/cpt.911 doi


Antimetabolites, Antineoplastic--administration & dosage
Capecitabine--administration & dosage
Clinical Decision-Making
Dihydrouracil Dehydrogenase (NADP)--genetics
Drug Dosage Calculations
Fluorouracil--administration & dosage
Genotype
Humans
Patient Selection
Pharmacogenetics--standards
Pharmacogenomic Testing--standards
Pharmacogenomic Variants
Phenotype
Precision Medicine--standards
Predictive Value of Tests